| FoxO transcription factors; Regulation by AKT and 14-3-3 proteins G Tzivion, M Dobson, G Ramakrishnan Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1813 (11), 1938-1945, 2011 | 902 | 2011 |
| Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities MLA Kollareddy M, Dimitrova E, Vallabhaneni KC, Chan A, Le T, Chauhan KM ... Nature Communications 12 (6), 7389, 2015 | 145* | 2015 |
| Sirt2 deacetylase is a novel AKT binding partner critical for AKT activation by insulin G Ramakrishnan, G Davaakhuu, L Kaplun, WC Chung, A Rana, A Atfi, ... Journal of Biological Chemistry 289 (9), 6054-6066, 2014 | 130 | 2014 |
| Bimodal regulation of FoxO3 by AKT and 14-3-3 M Dobson, G Ramakrishnan, S Ma, L Kaplun, V Balan, R Fridman, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1813 (8), 1453-1464, 2011 | 127 | 2011 |
| A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis CS Blaha, G Ramakrishnan, SM Jeon, V Nogueira, H Rho, S Kang, ... Nature Communications 13 (1), 899, 2022 | 58 | 2022 |
| The association between insulin and low-density lipoprotein receptors G Ramakrishnan, A Arjuman, S Suneja, C Das, NC Chandra Diabetes and Vascular Disease Research 9 (3), 196-204, 2012 | 39 | 2012 |
| AKT and 14-3-3 regulate Notch4 nuclear localization G Ramakrishnan, G Davaakhuu, WC Chung, H Zhu, A Rana, A Filipovic, ... Scientific reports 5 (1), 8782, 2015 | 38 | 2015 |
| CD36 maintains lipid homeostasis via selective uptake of monounsaturated fatty acids during matrix detachment and tumor progression AR Terry, V Nogueira, H Rho, G Ramakrishnan, J Li, S Kang, ... Cell metabolism 35 (11), 2060-2076. e9, 2023 | 33 | 2023 |
| Cell-autonomous versus systemic Akt isoform deletions uncovered new roles for Akt1 and Akt2 in breast cancer X Chen, MM Ariss, G Ramakrishnan, V Nogueira, C Blaha, W Putzbach, ... Molecular cell 80 (1), 87-101. e5, 2020 | 28 | 2020 |
| Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation ZI Carrero, M Kollareddy, KM Chauhan, G Ramakrishnan, LA Martinez Oncotarget 7 (11), 12554, 2016 | 17 | 2016 |
| Estradiol regulates insulin dependent stimulation of LDL-receptor expression in HepG2 cells NCC Gopalakrishnan R Indian Journal of Clinical Biochemistry 21 (1), 8 - 14, 2006 | 16 | 2006 |
| Study of low-density lipoprotein receptor regulation by oral (steroid) contraceptives: desogestrel, levonorgestrel and ethinyl estradiol in JEG-3 cell line and placental tissue G Ramakrishnan, A Rana, C Das, NC Chandra Contraception 76 (4), 297-305, 2007 | 15 | 2007 |
| Modulation by insulin of the co-localized LDL receptor in normal and type-I diabetic subjects S Suneja, G Ramakrishnan, N Tandon, NC Chandra International Journal of Clinical Medicine 2 (3), 231-245, 2011 | 9 | 2011 |
| NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma G Ramakrishnan, P Parajuli, P Singh, C Friend, E Hurwitz, C Prunier, ... Cell reports 41 (6), 2022 | 8 | 2022 |
| Characterization of cancer-associated missense mutations in MDM2 KM Chauhan, G Ramakrishnan, M Kollareddy, LA Martinez Molecular & cellular oncology 3 (2), e1125986, 2016 | 8 | 2016 |
| Deletion of AMP-activated protein kinase impairs metastasis and is rescued by ROS scavenging or ectopic CD36 expression G Ramakrishnan, AR Terry, V Nogueira, A Magdy, N Hay Cell Reports 44 (1), 2025 | 1 | 2025 |
| A novel non-catalytic scaffolding activity of Hexokinase 2 contributes to EMT and metastasis C Blaha, G Ramakrishnan, SM Jeon, H Rho, P Bhaskar, S Kang, ... bioRxiv, 2021.04. 08.439049, 2021 | | 2021 |
| Restoration of beta cell mass as a synthetic lethal strategy to overcome oncogenic Kras-driven pancreatic ductal adenocarcinoma T Nguyen, P Parajuli, A Ahmad, P Singh, S Eragameddy, ... MOLECULAR CANCER THERAPEUTICS 16 (10), 2017 | | 2017 |
| Abstract B32: Restoration of beta cell mass as a synthetic lethal strategy to overcome oncogenic Kras-driven pancreatic ductal adenocarcinoma T Nguyen, P Parajuli, A Ahmad, P Singh, S Eragameddy, ... Molecular Cancer Therapeutics 16 (10_Supplement), B32-B32, 2017 | | 2017 |
| Mutant p53 stabilizes and protects the transcription factor ETS2 from proteasomal degradation by the ubiquitin ligase COP1/DET1 ZI Carrero, M Kollareddy, KM Chauhan, G Ramakrishnan, LA Martinez Cancer Research 75 (15_Supplement), 1212-1212, 2015 | | 2015 |
